References
- Acharya S, Bussel J B. Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol 2000; 22: 62–65, [INFOTRIEVE], [CSA]
- Carey C L, Woods S P, Rippeth J D, Gonzalez R, Moore D J, Marcotte T D, Grant I, Heaton R K, Group H. Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clini Neuropsychol 2004; 18: 234–248, [CSA], [CROSSREF]
- Heaton R K, Marcotte T D, Mindt M R, Sadek J, Moore D J, Bentley H, McCutchan J A, Reicks C, Grant I, Group H. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc 2004; 10: 317–331, [INFOTRIEVE], [CSA], [CROSSREF]
- Lehrman G, Hogue I B, Palmer S, Jennings C, Spina C A, Wiegand A, Landay A L, Coombs R W, Richman D D, Mellors J W, Coffin J M, Bosch R J, Margolis D M. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 2005; 366: 549–555, [INFOTRIEVE], [CSA], [CROSSREF]
- Robinson B, Turchan J, Anderson C, Chauhan A, Nath A. Modulation of human immunodeficiency virus infection by anticonvulsant drugs. J NeuroVirol 2006; 12: 1–4, [INFOTRIEVE], [CSA], [CROSSREF]
- Schifitto G, Peterson D R, Zhong J, Ni H, Cruttenden K, Gaugh M, Gendelman H E, Boska M, Gelbard H. Valproic acid adjunctive therapy for HIV-associated cognitive impairment. A first report. Neurology 2006; 66: 919–921, [INFOTRIEVE], [CSA], [CROSSREF]
- Smith S M. Valproic acid and HIV-1 latency: beyond the sound bite. Retrovirology 2005; 2: 56, [INFOTRIEVE], [CSA], [CROSSREF]
- Ylisastigui L, Archin N M, Lehrman G, Bosch R J, Margolis D M. Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression. AIDS 2004; 18: 1101–1108, [INFOTRIEVE], [CSA], [CROSSREF]